News | November 01, 2010

New Technique Delays Brain Damage in Cardiac Arrest Victims

November 1, 2010 - After a heart attack victim stops breathing, a process of irreversible brain damage starts to occur within three to four minutes. But a new technique may significantly delay that damage.

While researching cardiac arrest, Jeffrey Dobkin read about a boy drowning in icy waters. Although submerged for more than half an hour the boy was rescued, resuscitated and he recovered completely.

Dobkin was curious as to how a drowning victim could experience no brain damage. He also wanted to see if the same principle could be applied to heart attack victims.

After researching the subject, Dobkin believes brain damage that occurs when someone's heart stops beating can be delayed for up to an hour.

"Cold water drowning victims survive without brain damage because of the triggering of the 'Mammalian Diving Reflex.' This natural reflex is solely responsible for delaying brain death," Dobkin said. "And the specific trigger of the diving reflex is a facial immersion in cold water."

The technique to delay brain damage in heart attack victims is simple: Immediately apply cold, wet compresses to the victim’s face. The emergency time-buying procedure delays brain damage until emergency medical personnel arrive. It works in conjunction with CPR.

"The eyes, the ophthalmic nerve, are the trigger points," says Dobkin. The Dobkin-Trigger Technique immediately starts to delay brain damage and gives emergency medical personnel a much greater "golden window" to respond to non-breathing victims than four minutes.

The Dobkin Technique works in heart attack victims - the fourth largest cause of death in the United States. It works to delay brain damage when the oxygen supply to the brain is shut off (Hypoxic-Ischemic Encephalopathy) for any reason, including drug overdose, choking, stroke, suffocation, electrocution.

For more information:

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init